These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 6271054)
1. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice. Klein RJ; DeStefano E; Friedman-Kien AE; Brady E Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054 [TBL] [Abstract][Full Text] [Related]
2. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs. Svennerholm B; Vahlne A; Lycke E Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097 [TBL] [Abstract][Full Text] [Related]
3. Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and L-lysine on latent ganglionic herpes simplex virus in vitro. Park NH; Pavan-Langston D; Declercq E Am J Med; 1982 Jul; 73(1A):151-4. PubMed ID: 6285706 [TBL] [Abstract][Full Text] [Related]
4. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice. Liu WG; Chen ZJ; Song JZ; Ma ZX Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367 [TBL] [Abstract][Full Text] [Related]
5. Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection. Klein RJ; DeStefano E; Brady E; Friedman-Kien AE Arch Virol; 1980; 65(3-4):237-46. PubMed ID: 6251784 [TBL] [Abstract][Full Text] [Related]
6. Effects of prolonged cultivation in the presence of acyclovir on recovery of latent herpes simplex virus from human trigeminal ganglia. Lewis ME; Warren KG; Jeffrey VM; Tyrrell DL Antimicrob Agents Chemother; 1983 Mar; 23(3):487-9. PubMed ID: 6303216 [TBL] [Abstract][Full Text] [Related]
7. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds. Klein RJ Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703 [TBL] [Abstract][Full Text] [Related]
8. Effect of eight antiviral drugs on the reactivation of herpes simplex virus in explant cultures of latently infected mouse trigeminal ganglia. Klein RJ; Friedman-Kien AE J Invest Dermatol; 1984 Nov; 83(5):344-6. PubMed ID: 6208291 [TBL] [Abstract][Full Text] [Related]
9. Effect of discontinuous acyclovir treatment on in vitro reactivation of herpes simplex virus from latently infected trigeminal ganglia. Klein RJ; Friedman-Kien AE; DeStefano E Antimicrob Agents Chemother; 1983 Jul; 24(1):129-31. PubMed ID: 6312871 [TBL] [Abstract][Full Text] [Related]
10. Novobiocin and coumermycin A1 inhibit viral replication and the reactivation of herpes simplex virus type 1 from the trigeminal ganglia of latently infected mice. Spivack JG; O'Boyle DR; Fraser NW J Virol; 1987 Oct; 61(10):3288-91. PubMed ID: 3041048 [TBL] [Abstract][Full Text] [Related]
11. In vitro effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5'-amino-5-iodo-2',5'-dideoxyuridine and 2-deoxy-D-glucose on latent ganglionic herpes simplex virus infection. Pavan-Langston D; Park NH; De Clercq E Antiviral Res; 1984 Apr; 4(1-2):53-61. PubMed ID: 6331305 [TBL] [Abstract][Full Text] [Related]
12. Specific inhibitors of herpes simplex virus thymidine kinase diminish reactivation of latent virus from explanted murine ganglia. Leib DA; Ruffner KL; Hildebrand C; Schaffer PA; Wright GE; Coen DM Antimicrob Agents Chemother; 1990 Jun; 34(6):1285-6. PubMed ID: 2168150 [TBL] [Abstract][Full Text] [Related]
13. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985 [TBL] [Abstract][Full Text] [Related]
14. Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection. Spivack JG; Fraser NW J Virol; 1988 May; 62(5):1479-85. PubMed ID: 2833602 [TBL] [Abstract][Full Text] [Related]
15. Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice. Klein RJ J Gen Virol; 1980 Aug; 49(2):401-5. PubMed ID: 6255074 [TBL] [Abstract][Full Text] [Related]
16. Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment. Klein RJ; Friedman-Kien AE; Yellin PB Infect Immun; 1978 Apr; 20(1):130-5. PubMed ID: 208970 [TBL] [Abstract][Full Text] [Related]
17. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient. Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729 [TBL] [Abstract][Full Text] [Related]
18. Effect of combined acyclovir and vidarabine on infection with herpes simplex virus in vitro and in vivo. Park NH; Callahan JG; Pavan-Langston D J Infect Dis; 1984 May; 149(5):757-62. PubMed ID: 6327850 [TBL] [Abstract][Full Text] [Related]
19. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo. Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910 [TBL] [Abstract][Full Text] [Related]